ELMEN; Joacim
Patent Applications and Registrations
Patent applications and USPTO patent grants for ELMEN; Joacim.The latest application filed is for "pharmaceutical composition".
- ELMEN; Joacim - Malmo SE
- Elmen; Joacim - Stockholm SE
- Elmen; Joacim - S-Malmo SE
| Patent | Date |
|---|---|
| Pharmaceutical Composition App 20210071181 - ELMEN; Joacim ; et al. | 2021-03-11 |
| Micromirs Grant 10,450,564 - Obad , et al. Oc | 2019-10-22 |
| Pharmaceutical Composition App 20190071672 - Elmen; Joacim ; et al. | 2019-03-07 |
| Micromirs App 20180201928 - Obad; Susanna ; et al. | 2018-07-19 |
| Pharmaceutical Composition App 20180195062 - Elmen; Joacim ; et al. | 2018-07-12 |
| MICROMIRs Grant 9,790,493 - Obad , et al. October 17, 2 | 2017-10-17 |
| Short interfering RNA (siRNA) analogues Grant 9,738,894 - Elmen , et al. August 22, 2 | 2017-08-22 |
| Short Interfering RNA (siRNA) Analogues App 20170009237 - Elmen; Joacim ; et al. | 2017-01-12 |
| Short interfering RNA (siRNA) analogues Grant 9,297,010 - Elmen , et al. March 29, 2 | 2016-03-29 |
| Pharmaceutical Composition for Inhibition of Disease-inducing microRNAs App 20160060627 - ELMEN; Joacim ; et al. | 2016-03-03 |
| MICROMIRs App 20150299699 - OBAD; Susanna ; et al. | 2015-10-22 |
| Pharmaceutical composition comprising anti-miRNA antisense oligonucleotides Grant 9,133,455 - Elmen , et al. September 15, 2 | 2015-09-15 |
| MicromiRs Grant 8,906,871 - Obad , et al. December 9, 2 | 2014-12-09 |
| Pharmaceutical Composition Comprising Anti-miRNA Antisense Oligonucleotides App 20140329883 - ELMEN; Joacim ; et al. | 2014-11-06 |
| Antisense oligonucleotides for inhibition of microRNA-21 Grant 8,729,250 - Elmen , et al. May 20, 2 | 2014-05-20 |
| Antisense oligomers targeting PCSK9 Grant 8,563,528 - Straarup , et al. October 22, 2 | 2013-10-22 |
| Combination treatment for the treatment of hepatitis C virus infection Grant 8,440,637 - Elmen May 14, 2 | 2013-05-14 |
| MicroRNAs Grant 8,288,356 - Obad , et al. October 16, 2 | 2012-10-16 |
| Pharmaceutical Composition Comprising Anti-miRNA Antisense Oligonucleotides App 20120238618 - Elmen; Joacim ; et al. | 2012-09-20 |
| Antisense Oligomers Targeting PCSK9 App 20120122954 - Straarup; Ellen Marie ; et al. | 2012-05-17 |
| Pharmaceutical composition comprising anti-mirna antisense oligonucleotide Grant 8,163,708 - Elmen , et al. April 24, 2 | 2012-04-24 |
| Pharmaceutical Composition App 20120083596 - Elmen; Joacim ; et al. | 2012-04-05 |
| MICROMIRs App 20100298410 - Obad; Susana ; et al. | 2010-11-25 |
| Pharmaceutical Composition Comprising Anti-Mirna Antisense Oligonucleotides App 20100286234 - Elmen; Joacim ; et al. | 2010-11-11 |
| Combination Treatment For The Treatment of Hepatitis C Virus Infection App 20100280099 - Elmen; Joacim | 2010-11-04 |
| Pharmaceutical Composition App 20100004320 - Elmen; Joacim ; et al. | 2010-01-07 |
| Lna Modified Phosphorothiolated Oligonucleotides App 20090176977 - Elmen; Joacim ; et al. | 2009-07-09 |
| MICROMIRs App 20090143326 - Obad; Susanna ; et al. | 2009-06-04 |
| Modified Short Interfering Rna (Modified Sirna) App 20080249039 - Elmen; Joacim ; et al. | 2008-10-09 |
| Short interfering rna (sirna) analogues App 20070191294 - Elmen; Joacim ; et al. | 2007-08-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 